Research progress in moderately hypofractionated radiotherapy for cancer
10.3760/cma.j.cn113030-20230508-00104
- VernacularTitle:恶性肿瘤中等大分割放疗的研究进展
- Author:
Zheng ZENG
1
;
Fuquan ZHANG
;
Ke HU
;
Junfang YAN
Author Information
1. 中国医学科学院 北京协和医学院 北京协和医院放射治疗科，北京 100730
- Keywords:
Neoplasms;
Moderately hypofractionated radiotherapy;
Research progress
- From:
Chinese Journal of Radiation Oncology
2024;33(2):184-188
- CountryChina
- Language:Chinese
-
Abstract:
Radiotherapy is one of the important treatment modalities for malignant tumors. Conventional fractionation is the most commonly-used radiotherapy mode, but it has disadvantages such as long treatment time and low efficiency, etc. With the advancement of radiotherapy equipment and technology, moderately hypofractionated radiotherapy has become the standard treatment for tumors such as breast cancer and prostate cancer, etc. However, the efficacy and safety of moderately hypofractionated radiotherapy have not been fully confirmed in a wider range of tumors. In this article, the application, efficacy, and safety of moderately hypofractionated radiotherapy in malignant tumors were reviewed.
